OBESITY INDICATORS AS RISK FACTORS FOR DIABETES AND HYPERTENSION

Authors

  • Rashad Mahmood Mirza Professor, Department of Physiology Asia International University, Bukhara, Uzbekistan Author

Keywords:

Anthropometric indices, Central adiposity, Diabetes mellitus, Hypertension, Waist circumference, Waist-to-hip ratio.

Abstract

Background: The global burden of diabetes and hypertension has risen sharply, establishing them as leading contributors to morbidity and mortality. Abdominal obesity indicators, such as waist circumference (WC) and waist-to-hip ratio (WHR), show a robust correlation with these disorders. Evidence suggests WC and WHR may be more effective predictors than body mass index (BMI). Aim and objectives: This study investigated the relationship between diabetes, hypertension, and various anthropometric parameters in adults aged 25–70 years. Objectives included quantifying BMI, WC, and WHR in adults with diabetes and/or hypertension, and evaluating the independent risk contributions of these measures. Materials and methods: A cross-sectional observational study was conducted at District Headquarter Hospital Bhimber, Azad Jammu and Kashmir, Pakistan, enrolling 100 participants (25–70 years). Subjects were divided into four groups (n=25 each): diabetics with normal blood pressure, hypertensives without diabetes, those with both conditions, and healthy controls. Physical measurements (weight, height, BMI, WC, WHR), random blood sugar (RBS), and blood pressure were recorded. Statistical analysis used ANOVA. Results: Most participants were aged 41–50 years, with a higher proportion of females. Mean BMI was significantly higher (p < 0.05) in groups with diabetes and/or hypertension compared to controls. Mean WC and WHR were significantly elevated (p< 0.05) in the group with coexisting diabetes and hypertension. Conclusion: Central obesity indicators (BMI, WC, WHR) show a significant association with diabetes and hypertension, underscoring their importance in risk stratification and public health strategy development.

References

1.Narayan KMV, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30(6):1562-6.

2.Tong Y, Xu S, Huang L, Chen C. Obesity and insulin resistance: pathophysiology and treatment. Drug Discov Today. 2022;27(3):822-30.

3.Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021; 137:111315.

4.Islam MS, Wei P, Suzauddula M, Nipa NJ, Sultana N, Hossain MA, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med. 2024;30(1):279.

5.Oh YS, Bae GD, Baek DJ, Park EY, Jun HS. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol. 2018; 9:384.

6.Blüher M. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? Clin Sci. 2016;130(18):1603-14.

7.Masuo K, Tuck ML, Lambert GW. Hypertension and diabetes in obesity. Int J Hypertens.

8.Kobayashi G, Shinozaki T, Okada H, et al. Associations between anthropometric indices as complementary predictors and incidence of type 2 diabetes; Panasonic Cohort Study 21. Diabetes Res Clin Pract. 2024; 217:111888.

9.Kawasoe S, Kubozono T, Salim AA, et al. Association between anthropometric indices and 5-year hypertension incidence in the general Japanese population. Hypertens Res. 2024; 47:867-76.

10.Khader Y, Batieha A, Jaddou H, et al. The performance of anthropometric measures to predict diabetes mellitus and hypertension among adults in Jordan. BMC Public Health. 2019;19(1):1416.

11.Liu XC, Liu YS, Guan HX, et al. Comparison of six anthropometric measures in discriminating diabetes: a cross-sectional study from the National Health and Nutrition Examination Survey. J Diabetes. 2022;14(7):465-75.

Downloads

Published

2026-07-12